Search All News
Columbia’s researchers have opened a trial of a noninvasive, focused ultrasound approach to open the blood-brain barrier, enabling higher concentrations of an effective drug to enter the brain.
Columbia pediatric brain tumor researchers are presenting several innovative studies at the 2022 ISPNO.
Columbia’s pediatric hematology/oncology/stem cell transplantation team is launching a groundbreaking program in pediatric neuro-oncology, the Brain Tumor Technology Research (BTTR) initiative.
Through new research studies Dr. Stergios Zacharoulis hopes to impact the currently dismal outlook for the 4,000 children in the US diagnosed each year with a brain or spinal cord tumor.